Übersetzung für "ultrasound study follow-up " (Englisch → Französisch) :

transrectal prostate ultrasonography | transrectal prostate ultrasound | transrectal prostate ultrasound examination | transrectal prostate ultrasound study | transrectal prostatic ultrasonography | transrectal prostatic ultrasound | transrectal ultrasonography | TRUS [Abbr.]

follow-up study [ follow-up study | prospective study | additional study ]

cohort study | prospective study | incidence study | follow-up study

Follow-up Study of French Immersion Graduates: Provincial Results; 1987-88 and 1988-89 graduates, 1991

A Follow-up Study of Child Hunger in Canada

Follow-up Committee on International Trade | Permanent Study Group on International Trade | Permanent Study Group on WTO and Other International Trade Agreements

renal ultrasonographic study | renal ultrasonography | renal ultrasound

Efficacy in the paediatric population may also need additional study following authorisation.

According to that Opinion, in a series of acute toxicity studies following oral administration of yessotoxins, no lethality and no clinical signs of toxicity were observed.

Dr Prawda graduated from the University of Leipzig with a degree in economic studies. He subsequently obtained a PhD degree in sociology as part of his doctoral studies followed at the Institute of Philosophy and Sociology of the Polish Academy of Science, after which he did research at the Institute’s Department of German Studies.

Question No. 53 Ms. Kirsty Duncan: With respect to the chronic cerebrospinal venous insufficiency (CCSVI) clinical trial being undertaken by Dr. Traboulse: (a) what milestones are reportable to the government, (i) on what date(s) is reporting expected to occur, (ii) how will this information be communicated to patients, the medical community, and the general public; (b) on what date did each of the trial sites pass ethical review; (c) on what date did recruitment of patients begin for each of the trial sites; (d) how many patients with multiple sclerosis (MS) are being recruited for each site, and how is consistency in diagnosis and treatment being ensured across sites; (e) who is performing the diagnoses for CCSVI for each site, (i) ho ...[+++]w is the diagnosis being performed, including, but not limited to, ultrasound and venogram, (ii) how many diagnoses has each person undertaking the diagnosis at each site performed prior to the study, and by whom was each person trained; (f) who is performing the procedures for each site, (i) how is the procedure being performed, including, but not limited to, anesthetic, balloon size, (ii) how many procedures has each person undertaking the procedure at each site performed prior to the study, and by whom was each person trained; (g) what are the selection criteria for the trial, including, but not limited to, type of MS, Expanded Disability Status Scale (EDSS) score, venous abnormality/malformed valve/stenosis, mobility, (i) how do these criteria compare with the international literature, (ii) with how many international studies to date will the selection criteria be analytically comparable; (h) if both progressive and relapsing-remitting forms of MS are to be examined in the trial, how will statistical significance be ensured given that 50 of 100 patients will undergo a “sham” procedure, 25 patients will have a progressive form of the disease, and 25 will have a relapsing-remitting form of the disease, and will people with bo ...